ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

6.3% Increase in Full Year 2024 Revenue Compared to Prior Year 13.0%…

Ericsson announces changes to the Executive Team and to the Market Area structure

Per Narvinger, currently Head of Business Area Cloud Software and Services, is…

IIIF150 Unveils Latest Flagship Raptor 5G at MWC2025

BARCELONA, Spain, Feb. 25, 2025 /PRNewswire/ — IIIF150, the imaginative ultra-thin rugged…

Flexport Unveils 20+ Tech and AI-Powered Products to Modernize Global Supply Chains

At the forefront of the launch are Flexport Intelligence with an AI…

DXC tapped by Skanska to Modernize Global IT Infrastructure

ASHBURN, VA, Feb. 25, 2025 /PRNewswire/ — DXC Technology, (NYSE: DXC), a…

India's Bharti Airtel partners Ericsson 5G Core technology to drive 5G evolution

New agreement spans packet core, signaling, charging & policy solutions STOCKHOLM, Feb.…

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI, Feb. 23, 2025 /PRNewswire/ — BioCity Biopharma (BioCity) announced that its selective…

China committed to acting as an 'enabler'

BEIJING, Feb. 25, 2025 /PRNewswire/ — A report from People’s Daily: Recently,…